A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This Phase 3 study was designed to demonstrate the net benefit of sotagliflozin versus placebo in patients with Type 1 Diabetes (T1D).
Epistemonikos ID: c097ed9742b471964cce9f2be1d06c67e6dd0bcf
First added on: May 12, 2024